X-rays affect the expression of genes involved in angiogenesis

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2941-2945

  Polytarchou, C ^a   Gligoris, T ^a   Kardamakis, D ^b   Kotsaki, E ^a   Papadimitriou, E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Heparin affin regulatory peptide; Nitric oxide synthase; Vascular endothelial growth factor; X rays

Indexed keywords

AGAROSE; HEPARIN AFFIN REGULATORY PEPTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FETUS; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMAGE ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; X IRRADIATION; X RAY;

ANIMALS; CARRIER PROTEINS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CYTOKINES; GENE EXPRESSION; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; X-RAYS;

EID: 6444228082     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Fuks Z, Vlodavsky I, Andreeff M, McLoughlin M and Haimovitz-Friedman A: Effects of extracellular matrix on the response of endothelial cells to radiation in vitro. Eur J Cancer 18A: 725-731, 1992.
2. Hatjikondi O, Ravazoula P, Kardamakis D, Dimopoulos J and Papaioannou S: In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity. Br J Cancer 74: 1916-1923, 1996.
3. Rose RW, O'Hara, MD, Williamson SK and Grant DS: The role of laminin-1 in the modulation of radiation damage in endothelial cells and differentiation. Radiat Res 152: 14-28, 1999.
4. Kaminski MJ, Majewski S, Kaminska G, Bem W and Szmurlo A: Enhancing effect of X ray irradiation on a new blood vessel formation in mice tested by lymphocyte induced angiogenesis assay. Arch Immunol Ther Exp 26: 1075-1078, 1978.
5. Kaminski MJ, Majewski S, Kaminska G, Bem W and Szmurlo A: Protease-mediated enhancement of lymphocyte-induced angiogenesis in X-rays irradiated mice. Int J Radiat Biol Relat Stud Phys Chem Med 43: 149-156, 1983.
6. Giannopoulou E, Katsoris P, Hatjiapostolou M, Kardamakis D, Kotsaki E, Polytarchou C, Parthymou A, Papaioannou S and Papadimitriou E: X Rays modulate extracellular matrix and enhance glioma cell induced angiogenesis. Int J Cancer 94: 690-698, 2001.
7. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
8. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
9. Kimura H and Esumi H: Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 50: 49-59, 2003.
10. Fukumura D and Jain RK: Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 17: 77-89, 1998.
11. Kroll J and Waltenberger J: VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998.
12. Zhang N and Deuel TF: Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol 6: 44-50, 1999.
13. Papadimitriou E, Polykratis A, Courty J, Koolwijk P, Heroult M and Katsoris P: HARP induces angiogenesis in vivo and in vitro: Implication of N or C terminal peptides. Biochem Biophys Res Commun 282: 306-313, 2001.
14. Polykratis A, Delbe J, Courty J, Papadimitriou E and Katsoris P: Identification of heparin affin regulatory peptide domains with potential role on angiogenesis. Int J Biochem Cell Biol 36: 1964-1976, 2004.
15. Pipili-Synetos E, Kritikou S, Papadimitriou E, Athanassiadou A, Flordellis C and Maragoudakis ME: Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane. Br J Pharmacol 129: 207-213, 2000.
16. Giannopoulou E, Katsoris P, Kardamakis D and Papadimitriou E: Amifostine inhibits angiogenesis in vivo. J Pharmacol Exp Ther 304: 729-737, 2003.
17. Polytarchou C and Papadimitriou E: Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. Free Radic Res 38: 501-508, 2004.
18. Giannopoulou E, Katsoris P, Polytarchou C and Papadimitriou E: Nitration of cytoskeletal proteins in the chicken embryo chorioallantoic membrane. Arch Biochem Biophys 400: 188-198, 2002.
19. Abdollahi A, Lipson KE, Sckell A, Zieher H, Klenke F, Poerschke D, Roth A, Han X, Krix M, Bischof M, Hahnfeldt P, Grone HJ, Debus J, Hlatky L and Huber PE: Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res 63: 8890-8898, 2003.
20. Auerbach R and Sidky YA: Nature of the stimulus leading to lymphocyte-induced angiogenesis. J Immunol 123: 751-754, 1979.
21. Giannopoulou E, Katsoris P, Parthymou A, Kardamakis D and Papadimitriou E: Amifostine protects blood vessels from the effects of ionizing radiation. Anticancer Res 22: 2821-2826, 2002.
22. Parthymou A, Kardamakis D, Pavlopoulos I and Papadimitriou E: Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro. Int J Cancer 110: 807-814, 2004.
23. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW and Weichselbaum RR: Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59: 3374-3378, 1999.
24. Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe DW and Weichselbaum RR: Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 394: 287-291, 1998.
25. Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD and Boucher Y: Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 60: 5565-5570, 2000.
26. Kozin SV, Boucher Y, Hicklin DJ, Bohlen P, Jain RK and Suit HD: Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res 61: 39-44, 2001.
27. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H and Hallahan DE: Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 61: 2413-2419, 2001.
28. Hess C, Vuong V, Hegyi I, Riesterer O, Wood J, Fabbro D, Glanzmann C, Bodis S and Pruschy M: Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth. Br J Cancer 85: 2010-2016, 2001.
29. Annabi B, Lee YT, Martel C, Pilorget A, Bahary JP and Beliveau R: Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3- gallate. Cancer Biol Ther 2: 642-649, 2003.
30. Mori K, Tani M, Kamata K, Kawamura H, Urata Y, Goto S, Kuwano M, Shibata S and Kondo T: Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells. Free Radic Res 33: 157-166, 2000.
31. Wild-Bode C, Weller M, Rimner A, Dichgans J and Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750, 2001.
32. Czubayko F, Schulte AM, Berchem GJ and Wellstein A: Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc Natl Acad Sci USA 93: 14753-14758, 1996.
33. Choudhuri R, Zhang HT, Donnini S, Ziche M and Bicknell R: An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 57: 1814-1819, 1997.
34. Cooke JP: NO and angiogenesis. Atheroscler Suppl 4: 53-60, 2003.
35. Morbidelli L, Donnini S and Ziche M: Role of nitric oxide in tumor angiogenesis. Cancer Treat Res 117: 155-167, 2004.
36. Dulak J and Jozkowicz A: Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 5: 123-132, 2003.
37. Koukourakis MI, Giatromanolaki A, Sivridis E and Fezoulidis I: Cancer vascularization: implications in radiotherapy? Int J Radiat Oncol Biol Phys 48: 545-553, 2000.